Current location - Music Encyclopedia - Chinese History - Medical beauty leading stocks rank in the top ten.
Medical beauty leading stocks rank in the top ten.
Medical cosmetology, referred to as medical cosmetology for short, refers to a cosmetic method that uses traumatic or irreversible medical technologies such as drugs, surgery and medical devices to repair and reshape people's appearance and various parts of the human body. Next, let's take a look at the top ten leading stocks in the medical and beauty industry: 1. Introduction of Aimeike: A leader in the medical beauty industry, the first enterprise in China to obtain the registration certificate of related products and medical devices. Products: solution injection products, gel injection products, facial implants, cosmetics. Valuation: total market value123.67 billion, P/B ratio 23.3 1, TTM P/E ratio15.89, which is 66% lower than the historical time. The valuation is moderate. 2. Introduction of Huaxi Biology: The main products are bioactive substances such as hyaluronic acid, and the end products are biomedical materials. Products: hyaluronic acid raw materials (excluding derivatives), medical terminal products-injection products, functional skin care products-disposable stock solution. Valuation: the total market value is 707 1 100 million, the price-to-book ratio is 1 1.64, and the TTM price-earnings ratio is 85.23, which is 76% lower than the historical time, so the valuation is low. 3. Brief introduction of Aoyuan Meigu: A-level medical beauty institution certified by China Plastic Surgery Association, whose main business is fiber new material business and medical beauty business. Products: viscose series, real estate sales, medical beauty services. Valuation: The total market value is 5.703 billion yuan, the P/B ratio is 4. 1 1, the TTM P/E ratio is loss, 27% lower than the historical time, and the valuation is on the high side. 4. Introduction of East China Medicine: The medical beauty industry mainly focuses on non-surgical mainstream medical beauty products such as facial fillers, body shaping, catgut embedding and energy devices. Products: Chinese and western medicine, medical equipment, differentiated sodium hyaluronate, collagen stimulator, botulinum toxin A, implant line, energy equipment. Valuation: The total market value is 74.68 billion, the P/B ratio is 4.3, and the TTM P/E ratio is 3 1.89, which is 38% lower than the historical time. The valuation is moderate. 5. Brief introduction of Haohai Ministry of Health: a biomedical high-tech enterprise focusing on research and development, production and sales of medical biomaterials. Products: ophthalmic products, medical beauty and wound care products, anti-adhesion and hemostasis products. Valuation: The total market value is 65.438+0.464 billion, the P/B ratio is 2.63, and the TTM P/E ratio is 46.3, which is 87% lower than the historical time and the valuation is low. 6. Ogilvy & Mather Medical Products Company Profile: In the field of disposable medical consumables such as medical dressings, there are few enterprises with complete industrial chains. Products: The company's products cover five series of wound care, surgery, infection prevention, medical combination bag and home care, and some products are used in advanced fields such as neurosurgery. Valuation: The total market value is 7.726 billion, the P/B ratio is 2.66, the TTM P/E ratio 16.35, which is 87% lower than the historical time, and the valuation is low. 7. Introduction of Langzi shares: The company holds three major domestic medical beauty brands: Milan Berrillo, Pure Skin Medical Beauty, and Gaoyisheng Medical Beauty, and strategically invests in the famous Korean medical beauty service group DMG. Products: women's coats, women's trousers, women's skirts, women's coats, baby clothes, baby products, surgical medical beauty, non-surgical medical beauty, consulting services. Valuation: The total market value is 65.438+0.334 billion, the P/B ratio is 4.54, and the TTM P/E ratio is 654.38+0.28.99, which is 25% lower than the historical time and the valuation is on the high side. 8. Introduction of Paofuni (female name): Kunming Weinuo, a subsidiary of the company, is mainly engaged in medical beauty services, including laser, microneedle and other beauty services. Products: facial cream, skin care lotion, facial mask, essence, lotion and other skin care products, facial cream, BB cream, makeup remover and other cosmetic products. Valuation: the total market value is 78 1. 1 billion, the price-to-book ratio is 15.94, and the TTM price-earnings ratio is 83.96, which is 90% lower than the historical time, and the valuation is extremely low. 9. Brief introduction of Shuiyang shares: HPH is a brand newly launched by the company in Light medical cosmetology. At present, it is mainly sold in Tmall, Jiyun and other channels, and the main operator is Yu Jiahui Holding Company. Products: facial mask, water cream, make-up, personal care, cleaning and other cosmetics. Valuation: The total market value is 66190,000, the P/B ratio is 3.9, and the TTM P/E ratio is 28.74, which is 80% lower than the historical time and the valuation is low. 10. Fang La naturalization introduction: The company's main business is washing, skin care and make-up products. Products: cream, conditioner, shower gel, shampoo, soap, gel water and gel cream. Valuation: The total market value is 3.003 billion.